- PR Newswire•2 days agoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Anthera Pharmaceuticals, Inc. (ANTH)
NEW YORK, Jan. 17, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Anthera Pharmaceuticals, Inc. ("Anthera" ...
- Business Wire•6 days agoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Violations of Federal Securities Laws by Certain Officers and Directors of Anthera Pharmaceuticals, Inc.
Levi & Korsinsky announces it has commenced an investigation of Anthera Pharmaceuticals, Inc. concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors.
- 24/7 Wall St.•20 days ago
December 30, 2016: Here are four stocks trading with relatively heavy volume among 66 equities making new 52-week lows in Friday’s session. On the NYSE, decliners led advancers by about 3 to 2 and on the ...
ANTH : Summary for Anthera Pharmaceuticals, Inc. - Yahoo Finance
Anthera Pharmaceuticals, Inc. (ANTH)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||0.61 x 700|
|Ask||0.67 x 3200|
|Day's Range||0.61 - 0.65|
|52 Week Range||0.61 - 4.90|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.42|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|